| Name | phospholipase A and acyltransferase 3 |
| Description | Enables N-acyltransferase activity; lipid binding activity; and phospholipase activity. Involved in N-acylphosphatidylethanolamine metabolic process. Predicted to be located in several cellular components, including lysosome; nuclear envelope; and peroxisome. Predicted to be active in cytoplasm. Biomarker of seminoma. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have shown that PLAAT3—also known by names such as PLA2G16, H‐REV107, AdPLA, and PLA/AT‐3—plays a central role in lipid and energy metabolism. In adipocytes, PLAAT3 regulates lipolysis and triglyceride storage as well as energy expenditure. For example, characterization of adipose‐specific PLA2 activity demonstrated that PLAAT3 hydrolyzes phospholipids to release free fatty acids and lysophospholipids, thereby modulating cAMP levels and prostaglandin signaling to control lipolysis and adiposity. Moreover, structural and biochemical evaluations have revealed a unique catalytic mechanism (involving a distinctive Cys–His–His triad) and dual PLA₁/PLA₂ activity that underpins its regulatory effects on fat metabolism, including in liver cells and conditions such as peripheral artery disease."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to metabolic regulation, PLAAT3 is emerging as a key modulator of tumor behavior. In several cancer types—including osteosarcoma, pancreatic adenocarcinoma, colorectal cancer, lung carcinoma, and prostate cancer—elevated PLAAT3 expression (often driven by mutant p53 or epigenetic alterations) has been linked to increased cell migration, invasion, and metastatic potential. Mechanistic studies have implicated PLAAT3 in regulating RAS activity and MAPK signaling, in part by modulating H‐RAS levels and interacting with factors such as ETS2 and TIG3 to affect tumor cell proliferation and apoptosis. Moreover, polymorphisms and methylation changes in the PLAAT3 gene locus have been associated with enhanced cancer risk and poorer patient prognosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "18"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in metabolism and oncogenesis, PLAAT3 has been implicated in additional cellular processes. Notably, it has been identified as a host factor required early in the infectious cycle of picornaviruses, where its lipid‐modifying activity facilitates viral genome delivery into the cytoplasm while counteracting autophagic clearance mechanisms. Moreover, PLAAT3 can interact with peroxin Pex19p to interfere with the assembly of peroxisomal membrane proteins, thereby regulating peroxisome biogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "19"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Robin E Duncan, Eszter Sarkadi-Nagy, Kathy Jaworski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and functional characterization of adipose-specific phospholipase A2 (AdPLA)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M804146200"}], "href": "https://doi.org/10.1074/jbc.M804146200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18614531"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18614531"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Kathy Jaworski, Maryam Ahmadian, Robin E Duncan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.1904"}], "href": "https://doi.org/10.1038/nm.1904"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19136964"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19136964"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Marcin Golczak, Philip D Kiser, Avery E Sears, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural basis for the acyltransferase activity of lecithin:retinol acyltransferase-like proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.361550"}], "href": "https://doi.org/10.1074/jbc.M112.361550"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22605381"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22605381"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Xiao-Yan Pang, Jian Cao, Linsee Addington, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure/function relationships of adipose phospholipase A2 containing a cys-his-his catalytic triad."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.398859"}], "href": "https://doi.org/10.1074/jbc.M112.398859"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22923616"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22923616"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Fu-Ming Tsai, Mao-Liang Chen, Lu-Kai Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "H-rev107 Regulates Cytochrome P450 Reductase Activity and Increases Lipid Accumulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0138586"}], "href": "https://doi.org/10.1371/journal.pone.0138586"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26381418"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26381418"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Caitlin Parmer, Ana Luisa De Sousa-Coelho, Henry S Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Skeletal muscle expression of adipose-specific phospholipase in peripheral artery disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Vasc Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1358863X20947467"}], "href": "https://doi.org/10.1177/1358863X20947467"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32853041"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32853041"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Karim Roder, Kee-Hong Kim, Hei Sook Sul "}, {"type": "b", "children": [{"type": "t", "text": "Induction of murine H-rev107 gene expression by growth arrest and histone acetylation: involvement of an Sp1/Sp3-binding GC-box."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S0006-291X(02)00440-0"}], "href": "https://doi.org/10.1016/S0006-291X(02"}, {"type": "t", "text": "00440-0) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12054741"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12054741"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Irina Nazarenko, Glen Kristiansen, Sabine Fonfara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "H-REV107-1 stimulates growth in non-small cell lung carcinomas via the activation of mitogenic signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2353/ajpath.2006.051341"}], "href": "https://doi.org/10.2353/ajpath.2006.051341"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17003497"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17003497"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Irina Nazarenko, Marcel Jenny, Jana Keil, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Atypical protein kinase C zeta exhibits a proapoptotic function in ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-09-0358"}], "href": "https://doi.org/10.1158/1541-7786.MCR-09-0358"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20501645"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20501645"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Chun-Hua Wang, Rong-Yaun Shyu, Chang-Chieh Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phospholipase A/Acyltransferase enzyme activity of H-rev107 inhibits the H-RAS signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biomed Sci (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1423-0127-21-36"}], "href": "https://doi.org/10.1186/1423-0127-21-36"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24884338"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24884338"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Shunbin Xiong, Huolin Tu, Madhusudhan Kollareddy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pla2g16 phospholipase mediates gain-of-function activities of mutant p53."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1404139111"}], "href": "https://doi.org/10.1073/pnas.1404139111"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25024203"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25024203"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Marcin Golczak, Avery E Sears, Philip D Kiser, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LRAT-specific domain facilitates vitamin A metabolism by domain swapping in HRASLS3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Chem Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nchembio.1687"}], "href": "https://doi.org/10.1038/nchembio.1687"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25383759"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25383759"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Hejia Wei, Lei Wang, Xiaobai Ren, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural and functional characterization of tumor suppressors TIG3 and H-REV107."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2015.04.002"}], "href": "https://doi.org/10.1016/j.febslet.2015.04.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25871522"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25871522"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Shoulei Liang, Zhiwu Ren, Xiuxin Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0127236"}], "href": "https://doi.org/10.1371/journal.pone.0127236"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25993412"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25993412"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Lin Li, Shoulei Liang, Amanda R Wasylishen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.7694"}], "href": "https://doi.org/10.18632/oncotarget.7694"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26933804"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26933804"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Xiao-Nv Xie, Jing Yu, Li-Hua Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Relationship between polymorphisms of the lipid metabolism-related gene PLA2G16 and risk of colorectal cancer in the Chinese population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Funct Integr Genomics (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10142-018-0642-8"}], "href": "https://doi.org/10.1007/s10142-018-0642-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30343388"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30343388"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "William E Jarrard, Adam Schultz, Tyler Etheridge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0218950"}], "href": "https://doi.org/10.1371/journal.pone.0218950"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31233548"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31233548"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Wei Xia, Hansong Bai, Ying Deng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.15832"}], "href": "https://doi.org/10.1111/jcmm.15832"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32985124"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32985124"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Jacqueline Staring, Eleonore von Castelmur, Vincent A Blomen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PLA2G16 represents a switch between entry and clearance of Picornaviridae."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature21032"}], "href": "https://doi.org/10.1038/nature21032"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28077878"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28077878"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Toru Uyama, Katsuhisa Kawai, Nozomu Kono, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interaction of Phospholipase A/Acyltransferase-3 with Pex19p: A POSSIBLE INVOLVEMENT IN THE DOWN-REGULATION OF PEROXISOMES."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.635433"}], "href": "https://doi.org/10.1074/jbc.M114.635433"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26018079"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26018079"}]}]}]}
|
| NCBI Gene ID | 11145 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
PLAAT3 has 4,435 functional associations with biological entities spanning 5 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 41 datasets.
Click the + buttons to view associations for PLAAT3 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PLAAT3 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of PLAAT3 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with PLAAT3 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with PLAAT3 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PLAAT3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of PLAAT3 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing PLAAT3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PLAAT3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of PLAAT3 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by PLAAT3 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PLAAT3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving PLAAT3 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving PLAAT3 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing PLAAT3 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing PLAAT3 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by PLAAT3 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by PLAAT3 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PLAAT3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of PLAAT3 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by PLAAT3 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of PLAAT3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of PLAAT3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| KEGG Pathways 2026 | pathways involving PLAAT3 protein from the KEGG Pathways 2026 dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of PLAAT3 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of PLAAT3 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by PLAAT3 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of PLAAT3 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MW Enzyme Metabolite Associations | interacting metabolites for PLAAT3 protein from the MW Gene Metabolite Associations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving PLAAT3 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving PLAAT3 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving PLAAT3 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PLAAT3 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of PLAAT3 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PLAAT3 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PLAAT3 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of PLAAT3 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of PLAAT3 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PLAAT3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PLAAT3 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PLAAT3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving PLAAT3 protein from the WikiPathways Pathways 2024 dataset. | |